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OBJECTIVE: To examine the presence of serum antinuclear autoantibodies in a healthy population.
METHODS: Serum of 500 normal blood donors between 18 and 60 years of age were tested for the presence of
autoantibodies. Antinuclear antibodies were detected by indirect immunofluorescence technique using HEp-2 epithelial
cells as the substrate. The presence of dnaN was detected by indirect immunofluorescence technique using Critidia lucillae
as the substrate. Anti-SSA (RO), anti-SSB (LA), anti-Sm, and anti-RNP were determined by double radial immunodiffusion.
RESULTS: In the evaluation of the presence of serum antibodies, antinuclear antibodies were detected in 22.6% of the
sera. The presence of other antibodies was not significant. The majority of the titers were 1:40.
CONCLUSION: The presence of autoantibodies is not necessarily pathologic and has to be related to the age group,
gender, and clinical condition of the patient.
DESCRIPTORS: Autoantibodies. Healthy population. Rheumatic diseases. Antinuclear antibodies. Autoimmunity.
Immune humoral response in the
presence of autoantibodies against in-
tracellular antigens characteristically
occurs in a majority of connective tis-
sue diseases. This phenomenon is
found in systemic lupus erythematous,
systemic sclerosis, Sjögren syndrome,
mixed connective tissue disease, poly-
myositis, and dermatomyositis, among
others1.
The detection of such autoanti-
bodies is important not only for diag-
nosis but also for the prognosis of the
diseases, in addition to allowing clini-
cal follow-up and treatment evaluation
in many cases1.
It is relevant to point out that in
healthy people and in patients with
non-rheumatic conditions, such as
chronic hepatic diseases, neoplasias, as
well as active infections including tu-
berculosis, malaria, and subacute bac-
terial endocarditis, these autoanti-
bodies may be present1. In general,
they are found in lower titers than
those detected in autoimmune dis-
eases. It is believed that such titers
may precede the appearance of dis-
eases in normal and asymptomatic in-
dividuals for many years2.
Previous studies have shown dif-
ferent prevalences of autoantibodies in
healthy populations. Baig and Shere
(1989), who investigated the serum of
blood donors and patients without
autoimmune diseases in Saudi Arabia,
found antinuclear antibodies (ANA)
present in 4.2%3. Vlam et al. (1993)
detected ANA present in 13% of nor-
mal blood donors in a Belgian popu-
lation2. Vazquez-Del Mercado et al.
(1995) reported that 4.7% of a Mexi-
can population tested positive for
ANA4.
The present study intends to evalu-
ate the prevalence of autoantibodies
in healthy people in relation to gen-
der and age group. It is important to
note that it is the first such study in
Brazil, one that characterizes a specific
population, that of blood donors of the
Pro-Blood Foundation – Hemocenter
of São Paulo, aiming to obtain param-
eters for comparisons with other popu-
lations.
All the samples were screened for
the presence of ANA using the indirect
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immunofluorescence technique in
HEp-2 cells. They were also tested for
the identification of antibodies against
antigens extracted from the nucleus
such as anti-SSA/RO, anti-SSB/LA,
anti-Sm, and anti-RNP by double ra-
dial immunodiffusion. They were still
tested for dnaN using indirect immun-
ofluorescence (IIF) technique with
Crithidia luciliae as the substrate.
In the blood bank, samples are ha-
bitually tested for infectious diseases
such as Chagas disease, syphilis, hepa-
titis B and C, HTLV-1 and HTVL-2, and
HIV-1 and HIV-2, that may contraindi-
cate the utilization of the blood taken.
This study was approved by the In-
stitutional Ethical Committee. The
volunteers who had significant titers
(ANA>1:160) for the studied param-
eters were informed of that and were
re-examined for any disease that could
be clinically confirmed. They received
follow-up evaluation and orientation
when necessary.
PATIENTS AND METHODS
Blood samples collection
The blood samples were collected
only after the volunteers had agreed to
take part in the study and after they
signed the consent form.. Five hundred
consecutive blood samples of volun-
teer donors (182 women and 318 men),
between 18 and 60 years of age, with
no clinical symptoms of any disease,
were analyzed (Fig. 1). They were ob-
tained from the Pro-Blood Foundation
– Hemocenter of São Paulo.
Autoantibody detection
After collection in plain red-top
tubes, the blood samples were centri-
fuged (10 minutes at 2000 rpm), and
the serum was separated into aliquots
for performing the autoantibody-de-
tection tests.
The indirect immunofluorescence
(IIF) technique to detect antinuclear
antibodies, described by Holbrow,
Weir, and Jonhson in 1957, was used
in slides covered with commercially
obtained (Hemagen®) HEp-2 cells (epi-
thelial cells of human larynx carci-
noma). The usage of human cells guar-
antees the presence of nuclear antigens
in such a concentration that enables
the confirmation of the presence of
antibodies in the serum.
At first, a screening test was carried
out, in which serum samples were di-
luted in phosphate-buffered saline, pH
7.4 (PBS) to a titer of 1:40 to detect
positive reaction and characterization
of the fluorescence pattern. The posi-
tive samples were titered until testing
negative.
The HEp-2 cells were incubated
with the donor’s serum samples in a
humid and dark camera for 30 minutes
and were then washed in PBS. After-
wards they were incubated with human
anti-IgG antibody marked with fluo-
rescein isothiocyanate. After being
washed again, the slides were mounted
with buffered glycerine pH 8. A Zeiss
microscope equipped for epilumines-
cence was used for reading the slides.
In order to detect native anti-DNA
autoantibodies (DNAn), the indirect
immunofluorescence (IIF) technique
was used in slides covered with
Crithidia lucillae (a protozoan that is
rich in kinetoplast DNA) obtained from
the Department of Rheumatology of
our Institution.
The slides were incubated with the
samples diluted 1:20 in Tris-buffered
saline, pH 7.5 (TBS) and were then
washed and incubated with human
anti-IgG antibody (SIGMA brand)
marked with fluorescein isothiocya-
nate. A Zeiss microscope equipped for
epiluminescence was used for reading
the slides (immersion objective).
The double radial immunodiffu-
sion technique, described by O.
Ouchterlony in 1949, was used to in-
vestigate anti-SSA (RO), anti-SSB
(LA), anti-Sm, and anti-RNP antibod-
ies. The reaction was run on 0.6%
agarose. The sources of antigens were
extracted from the human spleen for
SSA and rabbit thymus extract (Sigma
brand) for anti-SSB, anti-Sm, and anti-
RNP. The positive controls were com-
mercially obtained (IMMCO brand).
Petri plates with agarose gel were
perforated to restrain the samples (non-
diluted serum), the controls, and the
source of antigen. The plates were
visually analyzed over a period of 24
to 48 hours for observation of the for-
mation (positive) or non-formation
(negative) of lines of immunopre-
cipitation between the samples and the
controls.
Infectious diseases serology
The Pro-Blood Foundation –
Hemocenter of São Paulo uses the fol-
lowing techniques to investigate infec-
tious diseases in the blood of donors:
ELISA and VDRL for syphilis; ELISA,
and if positive, Western - Blot for HIV;
ELISA for HTLV; ELISA, indirect
hemaglutination and indirect immun-
ofluorescence (IIF) for Chagas disease
and ELISA for hepatitis B.
Statistical analysis
The statistical analysis was per-
formed by the Department of Preven-
tive Medicine of our Institution. The
c2 test was used, adopting the value
of P less than or equal to 5% as the
indicator for statistical significance.
The statistical analysis was carried out
with the software STATATM (Statistical/
Data Analysis), version 7.0.
RESULTS
The study involved 318 men
(63.6%) and 182 women (36.4%). The
average age of the donors was 33.1
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years (standard deviation = 9.7 years
of age). No association was found be-
tween gender and age of the donors (P
= 0.27) (Table 1; Fig.1). Out of the 500
donors included in the sample, 113
were positive for ANA, representing a
prevalence of 22.6% (CI95%:18.9% to
26.3%) as shown in figure 2. Among
the donors who presented ANA+, 73
(64.6%) had a titer of 1:40, 23 (20.4%)
a titer of 1:80, 10 (8.8%) a titer of
1:160, and 7 (6.2%) a titer equal or
higher than 1:320. Out of this last
group, 1 donor presented a titer of
1:320, 2 donors 1:1280, 2 others
1:2560, 1 a titer of 1:5120, and an-
other of 1:10240. Titers of ANA equal
to or higher than 1:320 are considered
pathological in the literature, and 7 of
the 500 donors included in the study
presented titers in this category, which
corresponds to a prevalence of 1.4%
(CI95%: 0.3 to 2.4). The prevalence of
ANA among the donors included in
the study according to the different
titers found is shown in table 2. The
prevalence of other autoantibodies was
very low: 1 donor presented anti-SM+
(and did not present ANA+), and 2
other donors presented anti-RO+ (one
with ANA+ 1:40 and another with
ANA+ 1:10240). The association be-
tween gender and age group and the
presence of ANA+ (in any titer) is
shown in table 3. Female blood donors
presented a higher risk of presenting
ANA+ (PR =1.66; CI95%:1.20 to 2.28).
As for the age group, donors under 40
years of age presented a tendency to a
smaller prevalence of ANA+, with no
statistical significance. The risk of pre-
senting ANA+ according to gender did
not present any significant alterations
after the age adjustment (PR = 1.62;
CI95%: 1.18 to 2.21), which means that
age was not a confounding variable for
this association. Only a few donors pre-
sented ANA titers equal to or higher
than 1:320, and this hindered the in-
vestigation of the characteristics asso-
ciated with such titers. There was a
Table 2 - Prevalence of ANA+ of the volunteer blood donors included in the
study, according to different titers (n=500).
ANA (titer) N Prevalence (%)  CI95% (%)
1:40 73  14.6  11.5 to 17.7
1:80 23  4.6  2.8 to 6.4
1:160 10  2.0  0.8 to 3.2
1:320 or more 7  1.4  0.3 to 2.4
Any titer 113  22.6  18.9 to 26.3
Table 1 - Distribution by gender and age group of the volunteer blood donors
included in the study (n=500).
MEN  WOMEN TOTAL
Age group N % N % N %
Up to 30 149 46.9 84 46.1 233 46.6
31 to 40 109 34.3 52 28.6 161 32.2
41 to 50 38 11.9 32 17.6 70 14.0
51 to 60 22 6.9 14 7.7 36 7.2
Figure 2 - Percentage of antinuclear antibodies positive in each age group, according to
gender.
Figure 1 - Total number of blood donors, distributed according to gender and age group.
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marginally significant tendency to-
wards the presence of higher titers of
ANA+ (PR = 4.4; CI95%: 0.9 to 22.3)
among females, and no association was
found between age group and titers of
ANA higher than 1:320 (Table 4,
Fig.3).
As for serologies for infectious dis-
eases, only 2 donors presented positive
serology for hepatitis B (anti-HBc) and
were ANA positive with low titers
(1:40).
DISCUSSION
Antinuclear antibodies (ANA) are
present in some autoimmune diseases
and in other non-autoimmune condi-
tions, as mentioned before. In the
autoimmune diseases, testing for ANA
is considered a useful screening test
due to its high sensitivity and low
specificity. For instance, in case of sys-
temic lupus erythematous, a positive
test with titers higher than 1:40 and
1:80 presents a positive predictive
value of 15% to 35%, indicating the
need to complement the investigation
with tests for other autoantibodies such
as anti-DNAn, anti–RO, anti-Sm, and
anti-LA2. In face of a positive test for
ANA, in addition to the patient clini-
cal profile, some other conditions have
to be taken into consideration, such as
the presence of positive serologies for
hepatitis B and C, HIV, HTLV, Chagas
disease, and syphilis, since patients
with such diseases may test positive
for ANA although in low titers2. In the
present study, 2 out of the 112 ANA-
positive samples presented positive
serology for hepatitis B (ANA being
found in low titers: 1:40), which may
represent a false positive result due to
the hepatitis. That is why it is always
important to exclude the possibility of
any infectious disease in face of a posi-
tive result for ANA in low titers.
In the present study, the prevalence
of ANA in the general population was
22.6%, higher than the prevalences
found in the literature, which vary from
4% to 13%3,5,6,7. The majority had low
titers (83.9% with titers of 1:40 and
1:80), which is in accordance with the
results obtained by other authors2,8. In
10 donors (8.9%), the ANA titer was
1:160, which is considered an interme-
diate value2. Since there are few stud-
ies of this kind in the literature and
most of them deal with the European
population, which does not have the
same ethnic characteristics as ours, it
is difficult to determine whether this
incompatible result is due to any idi-
osyncrasy of the sample studied. In or-
der to clarify this point, it would be
preferable if this study were applied in
other populations. Taking into consid-
eration that 8 of the observed donors
presented ANA>1:160, a titer consid-
ered significant for the diagnosis of
collagenosis, it is advisable that such
donors, although clinically healthy,
should receive follow-up evaluation in
order to detect any sign of the devel-
opment of an autoimmune disease.
Two of the observed donors presented
positive anti-RO, one of them with an
ANA titer of 1:160 and the other ANA
Table 3 - Prevalence ratios of ANA+ in any titer, according to age group and
gender.
Characteristic Total ANA+ % PR CI95% P
Gender
Male 318 58 18.2 1.0
Female 182 55 30.2 1.66 1.20 to 2.28 0.002
Age group
41 or older 106 30 28.3 1.0
Up to 40 394 83 21.1 0.74 0.52 to 1.06 0.11
Table 4 - Prevalence ratios of antinuclear antibodies titers equal to or higher than
1:320, according to gender and age group.
Characteristic Total  FAN+ % PR CI95% P>1:320
Gender
Male 318  2 0.6 1.0
Female 182  5 2.7 4.4 0.9 to 22.3 0.06
Age group
41 or older 106  1 0.9 1.0
Up to 41 394 6 1.5 1.6 0.2 to 13.2 0.65
Figure 3 - Percentage of antinuclear antibodies positive in each titer group, according to
gender.
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titer of 1:40. The positivity of such an
antibody associated with ANA signifi-
cantly increases the possibility of an
autoimmune disease that is not clini-
cally detectable at the present moment
or that has not yet developed. There-
fore, these 2 donors should be segre-
gated from the ANA+ assuredly
healthy population, reducing the
positivity of such an autoantibody in
the healthy individuals to 20.6%.
Concerning gender, there was a higher
positivity of ANA among females,
which agrees with the available data
in the literature3,5,6,9. As for ANA dis-
tribution among age groups, there was
no statistical difference, which contra-
dicts the observations reported in the
literature of higher positivity of
autoantibodies, including those of
ANA, in the elderly as a result of the
loss of autoregulation of the immune
system due to senescence3,5,10.
CONCLUSION
This paper reports on a study of a
specific population of blood donors
between 18 and 60 years of age. Al-
though it does not cover all the age
groups, it allows the following conclu-
sions based on the ones observed:
1. ANA may be positive in low titers
in the normal population, not nec-
essarily being an indicator of col-
lagenosis.
2. Infectious contagious diseases may
lead to positivity for ANA although
in low titers.
3. ANA positivity in healthy indi-
viduals was higher among females.
4. Positivity for other autoantibodies
was low and not always related to
the positivity of ANA.
5. The present study leads the way to
population studies in Brazil so that
we may have a chart of ANA and
of other autoantibody positivity in
different population groups in our
country.
RESUMO
FERNANDEZ SAV e col. - Prevalência
de auto-anticorpos antinucleares
no soro de doadores de sangue
normais. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(6):315-319,
2003.
OBJETIVO: O objetivo deste tra-
balho foi detectar a presença de auto-
anticorpos em pessoas sadias.
MÉTODOS: Foi estudado o soro
de 500 doadores de sangue sadios,
com idade entre 18 e 60 anos. Anti-
corpo antinuclear foi detectado por
imunofluorescência indireta usando
células Hep-2 como substrato. A pes-
quisa de anti-DNA-nativo (DNA-n) foi
feita com a técnica de imunofluo-
rescência indireta usando Critidia
lucillae como substrato. A pesquisa de
anti-SSA, anti-SSB, anti-Sm e anti-
RNP foi feita utilizando a técnica de
imunodifusão radial dupla.
REUSLTADOS: A presença de
anticorpo antinuclear foi detectada em
22,6% das amostras estudadas. A mai-
oria apresentou títulos 1/40. A presen-
ça de outros anticorpos não foi signi-
ficativa.
CONCLUSÃO: A presença de auto-
anticorpos não é necessariamente pa-
tológica e deve ser correlacionada à
idade, sexo e condição clínica do pa-
ciente.
DESCRITORES: Autoanticorpos.
População Sadia. Doenças Reumáti-
cas. Anticorpos Antinucleares.
Autoimunidade.
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